£30M clinical study will enhance the understanding of NASH cirrhosis

The most extensive clinical study into liver cirrhosis ever conducted worldwide has been announced by Newcastle University, University of Edinburgh and leading research-driven global biopharmaceutical company, Boehringer Ingelheim.

Pfizer’s reset year starts with a little profit

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

January 31, 2024

A rare voice box transplant helped a cancer patient speak again, part of a pioneering study

WASHINGTON — A Massachusetts man has regained his voice after surgeons removed his cancerous larynx and, in a pioneering move, replaced it with a donated

July 9, 2024

New compound extracted from African catfish skin mucas exhibits powerful antibacterial properties

Scientists report they have extracted a compound with powerful antibacterial properties from the skin of farmed African catfish.

March 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.